NIH: Integration and Validation of Emerging Technologies to Accelerate Cancer Research (R33) [RFA-CA-17-023]


This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer Moonshot Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research on the advanced development and rigorous validation of new enabling technologies/tools/capabilities with a transformative potential for cancer research and clinical oncology. Specifically, this FOA targets the following four areas designated as scientific priorities:

  • Enhanced experimental and analytical capabilities addressing complexities of cancer development;
  • New capabilities advancing precise clinical diagnosis of cancer patients;
  • Novel predictive ex vivo and/or in silico modeling approaches; and
  • New technologies/approaches to improve biospecimen and data quality.

For info and to apply visit https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-17-023.html